ProShare Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Sell
13,280
-3,536
-21% -$73.6K ﹤0.01% 1370
2025
Q4
$360K Buy
16,816
+734
+5% +$15K ﹤0.01% 1342
2025
Q3
$269K Sell
16,082
-2,952
-16% -$44.2K ﹤0.01% 1508
2025
Q2
$273K Sell
19,034
-1,233
-6% -$16.9K ﹤0.01% 1515
2025
Q1
$294K Sell
20,267
-5,680
-22% -$80.7K ﹤0.01% 1431
2024
Q4
$340K Buy
25,947
+8,344
+47% +$115K ﹤0.01% 1528
2024
Q3
$204K Buy
17,603
+4,675
+36% +$44.1K ﹤0.01% 1719
2024
Q2
$97.6K Sell
12,928
-4,009
-24% -$33.2K ﹤0.01% 1668
2024
Q1
$170K Buy
16,937
+1,167
+7% +$10.9K ﹤0.01% 1712
2023
Q4
$147K Buy
15,770
+2,992
+23% +$30.9K ﹤0.01% 1713
2023
Q3
$162K Sell
12,778
-327
-2% -$4.49K ﹤0.01% 1531
2023
Q2
$186K Buy
13,105
+1,243
+10% +$17.5K ﹤0.01% 1556
2023
Q1
$177K Sell
11,862
-1,052
-8% -$15.9K ﹤0.01% 1489
2022
Q4
$192K Buy
12,914
+1,460
+13% +$23.8K ﹤0.01% 1511
2022
Q3
$189K Sell
11,454
-670
-6% -$13.5K ﹤0.01% 1423
2022
Q2
$254K Sell
12,124
-5,131
-30% -$105K ﹤0.01% 1312
2022
Q1
$405K Sell
17,255
-2,097
-11% -$51.3K ﹤0.01% 1430
2021
Q4
$528K Buy
19,352
+7,340
+61% +$197K ﹤0.01% 1396
2021
Q3
$342K Sell
12,012
-10,112
-46% -$308K ﹤0.01% 1452
2021
Q2
$667K Sell
22,124
-381
-2% -$11.2K ﹤0.01% 1317
2021
Q1
$573K Buy
22,505
+4,277
+23% +$110K ﹤0.01% 1345
2020
Q4
$447K Buy
18,228
+3,257
+22% +$61.2K ﹤0.01% 1338
2020
Q3
$244K Sell
14,971
-3,418
-19% -$63.6K ﹤0.01% 1310
2020
Q2
$314K Buy
+18,389
New +$273K ﹤0.01% 1203
2020
Q1
Sell
-9,193
Closed -$255K 1414
2019
Q4
$255K Buy
+9,193
New +$231K ﹤0.01% 1440
2019
Q3
Sell
-9,026
Closed -$228K 1676
2019
Q2
$228K Sell
9,026
-1,845
-17% -$49.6K ﹤0.01% 1365
2019
Q1
$295K Buy
10,871
+2,265
+26% +$75.9K ﹤0.01% 1267
2018
Q4
$284K Sell
8,606
-2,458
-22% -$98.8K ﹤0.01% 1188
2018
Q3
$516K Buy
11,064
+715
+7% +$32.8K ﹤0.01% 1088
2018
Q2
$448K Sell
10,349
-22
-0.2% -$1.05K ﹤0.01% 1170
2018
Q1
$577K Sell
10,371
-304
-3% -$16.7K ﹤0.01% 1043
2017
Q4
$570K Buy
10,675
+2,411
+29% +$114K ﹤0.01% 1067
2017
Q3
$356K Sell
8,264
-192
-2% -$9.13K ﹤0.01% 1080
2017
Q2
$510K Sell
8,456
-1,438
-15% -$85.2K 0.01% 958
2017
Q1
$686K Sell
9,894
-447
-4% -$31K 0.01% 891
2016
Q4
$689K Buy
10,341
+1,722
+20% +$112K 0.01% 936
2016
Q3
$571K Sell
8,619
-2,287
-21% -$156K 0.01% 895
2016
Q2
$790K Sell
10,906
-133
-1% -$9.14K 0.01% 788
2016
Q1
$713K Sell
11,039
-1,148
-9% -$76.2K 0.01% 848
2015
Q4
$873K Buy
12,187
+1,164
+11% +$86.1K 0.01% 798
2015
Q3
$846K Sell
11,023
-5,843
-35% -$471K 0.01% 732
2015
Q2
$1.25M Sell
16,866
-1,034
-6% -$74.4K 0.02% 673
2015
Q1
$1.3M Sell
17,900
-3,151
-15% -$219K 0.02% 722
2014
Q4
$1.39M Sell
21,051
-33,279
-61% -$2.03M 0.02% 704
2014
Q3
$2.98M Buy
54,330
+5,895
+12% +$334K 0.04% 504
2014
Q2
$2.82M Buy
48,435
+35,006
+261% +$2.06M 0.04% 548
2014
Q1
$832K Sell
13,429
-61,725
-82% -$3.59M 0.01% 1450
2013
Q4
$4.01M Buy
75,154
+63,542
+547% +$3.41M 0.06% 390
2013
Q3
$583K Buy
11,612
+3,784
+48% +$185K 0.01% 1331
2013
Q2
$358K Buy
+7,828
New +$350K 0.01% 1569

Other funds holding MD

ProShare Advisors's MD Position: Q1 2026 in Review

ProShare Advisors reduced its Pediatrix Medical (MD) stake by 21% in Q1 2026, selling an estimated $73.6K and leaving 13,280 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

ProShare Advisors first reported a position in MD in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.01M in Q4 2013. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • ProShare Advisors held 13,280 shares of Pediatrix Medical worth $284K as of Q1 2026.
  • ProShare Advisors sold 3,536 Pediatrix Medical shares in Q1 2026, an estimated $73.6K.
  • Pediatrix Medical made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1370 holding.
  • ProShare Advisors first reported a position in Pediatrix Medical in Q2 2013 and has held it in 50 quarters since.
  • ProShare Advisors's Pediatrix Medical position peaked at $4.01M in Q4 2013.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.